Delivering a step forward for rare disease patients
09/13/23 • 30 min
Dr Ellie Cannon is joined by Dr. Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK, to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.
PP-UNP-GBR-6142 / August 2023
Dr Ellie Cannon is joined by Dr. Jacqueline Barry, Chief Clinical Officer at the Cell and Gene Therapy Catapult and Owen Marks, Rare Disease Lead at Pfizer UK, to discuss the urgent need to evolve the way rare disease medicines are brought to patients, and why healthcare systems need to keep pace with scientific advancements.
PP-UNP-GBR-6142 / August 2023
Previous Episode
Meeting the challenge of Antimicrobial Resistance (AMR)
Dr Ellie Cannon is joined by economist Lord Jim O’Neill (who in 2014 was commissioned to chair a review into the rising increase in drug-resistant infections) and Toby Cousens, Hospital and Internal Medicines Lead at Pfizer UK (at time of recording), to discuss the threat of antimicrobial resistance (AMR) and the challenges it poses both to science and wider society.
PP-UNP-GBR-11741 / March 2025
Next Episode
Innovation in cancer: Defining the future of care
Dr Ellie Cannon is joined by Jane Lyons, CEO of Cancer52 and Stefano Podesta, Oncology Lead at Pfizer UK, to discuss the big challenges and opportunities in the fight against cancer within the UK.
PP-UNP-GBR-7436 / November 2023
If you like this episode you’ll love
Episode Comments
Generate a badge
Get a badge for your website that links back to this episode
<a href="https://goodpods.com/podcasts/breakthroughs-373845/delivering-a-step-forward-for-rare-disease-patients-53538647"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to delivering a step forward for rare disease patients on goodpods" style="width: 225px" /> </a>
Copy